Autoantibodies and HLA susceptibility markers in Canadian first-degree relatives of patients with type 1 diabetes

Annals of the New York Academy of Sciences

Volumn 958, Issue , 2002, Pages 228-231

  Behme, M T ^a,b   Mahon, J L ^a   Dupre J ^a  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b Siebens Drake Research Institute   (Canada)

Author keywords

Autoantibodies; Diabetes susceptibility; HLA

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; HLA ANTIGEN; INSULIN; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ADULT; AUTOIMMUNE DISEASE; CANADA; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE PREDISPOSITION; FEMALE; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATHOGENESIS; RELATIVE;

EID: 0036271768     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb02975.x     Document Type: Conference Paper

References (4)

1. Can we prevent IDDM?
2. Islet cell antibody and HLA markers in first degree relatives of patients with type 1 diabetes mellitus (abstract)
3. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes
4. Islet cell antibody-positive relatives with human leukocyte antigen DQA1*0102, DQB1*0602: Identification by the Diabetes Prevention Trial-type 1